Literature DB >> 2058763

Is cystic disease related to breast cancer?

D E Haagensen1.   

Abstract

Human breast cystic disease is a common premenopausal benign breast condition. Apocrine metaplasia of normal breast epithelium is the lesion that allows cysts to develop. Apocrine metaplasia and breast cysts occur frequently in association with other proliferative changes in breast epithelium, especially breast epithelial hyperplasia. Clinical follow-up studies of women with breast cystic disease indicate an increased risk of subsequent development of breast carcinoma. This risk is enhanced when multiple cysts occur. A positive family history of breast carcinoma adds to the increased risk that is associated with breast cystic disease. Biochemical analysis of breast cystic disease fluid shows a unique protein profile. GCDFP-15 (gross cystic disease fluid protein) in breast cystic disease fluid is also found by immunoperoxidase staining to be present in approximately 50% of all breast carcinomas Enhanced production of GCDFP-15 by breast carcinomas has been shown experimentally and clinically with the use of androgens. A hypothesis is presented on the sequence of alterations that relate to the development of breast gross cystic disease and to the development of breast carcinomas with apocrine features.

Entities:  

Mesh:

Year:  1991        PMID: 2058763     DOI: 10.1097/00000478-199107000-00010

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.

Authors:  C Jones; S Damiani; D Wells; R Chaggar; S R Lakhani; V Eusebi
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 2.  Evaluation and management of high risk and premalignant lesions of the breast.

Authors:  D L Page; R A Jensen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

3.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

4.  PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.

Authors:  A Pagani; A Sapino; V Eusebi; P Bergnolo; G Bussolati
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Obesity is associated with atypia in breast ductal lavage of women with proliferative breast disease.

Authors:  Zora Djuric; Ann Edwards; Shashi Madan; Linda Darga; Jianwei Ren; Cassann Blake; Mathew Koletsky; Lance K Heilbrun
Journal:  Cancer Epidemiol       Date:  2009-07-28       Impact factor: 2.984

6.  Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.

Authors:  Trine Tramm; Jee-Yeon Kim; Sebastian Leibl; Farid Moinfar; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2016-06-10       Impact factor: 4.064

Review 7.  Non-operative breast pathology: apocrine lesions.

Authors:  C A Wells; G A El-Ayat
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

8.  Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.

Authors:  D E Haagensen; P Stewart; W G Dilley; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia.

Authors:  W Tschugguel; W Knogler; K Czerwenka; M Mildner; W Weninger; R Zeillinger; J C Huber
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

10.  Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.

Authors:  R E Hall; J A Clements; S N Birrell; W D Tilley
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.